Weekly Top Insider Buys: Monsanto Company, SAIC Inc., Natural Resource Partners L.P., Sonic Corp., and Spectrum Pharmaceuticals Inc.

Weekly Top Insider Buys: MON, SAI, NRP, SONC, SPPI

Author's Avatar
Apr 18, 2010
Weekly highlight of top insider buys: Monsanto Company (MON, Financial), SAIC Inc. (SAI, Financial), Natural Resource Partners L.P. (NRP, Financial), Sonic Corp. (SONC, Financial), and Spectrum Pharmaceuticals Inc. (SPPI, Financial).


Director of Monsanto Company, Charles S Mcmillan, bought 2,000 shares on 4/14/10 at an average price of $64.73.


Monsanto is a global provider of technology-based solutions and agricultural products for growers and downstream customers, such as grain processors and consumers, in the agricultural markets. Monsanto Company has a market cap of $35.32 billion; its shares were traded at around $64.73 with a P/E ratio of 22 and P/S ratio of 3. The dividend yield of Monsanto Company stocks is 1.5%. Monsanto Company had an annual average earning growth of 18.2% over the past 10 years.


Monsanto reported second-quarter earnings of $887 million, or $1.60 per share, down from $1.1 billion, or $1.97 it reported for the same period last year. Revenue was down from $4 billion to $3.9 billion. Monsanto expects EPS of $3.10-$3.30 in fiscal 2010. The consensus estimate is for EPS of $3.27.


Monsanto Company is in the portfolios of ten Gurus: Wallace Weitz, George Soros, Chris Davis, PRIMECAP Management, Kenneth Fisher, Irving Kahn, Jean-Marie Eveillard, Steve Mandel, Ron Baron, and John Griffin.


Last week, Buy:: Director Charles S Mcmillan bought 2,000 shares of MON stock. Sell:: Exec. VP Human Resources Steven Mizell, Sell:: VP, Vegetable Business Consuelo E. Madere, and


Sell:: EVP, Chief Technology Officer Robert T Fraley sold shares in January.


SAIC Inc. (SAI): Director Thomas F Frist III Bought 140,000 Shares


Director of SAIC Inc., Thomas F Frist III, bought 140,000 shares on 4/13/10 at an average price of $17.97.


SAIC INC is a scientific, engineering, and technology applications company that uses its deep domain knowledge to solve problems of vital importance to the nation and the world, in national security, energy and the environment, critical infrastructure, and health. Saic Inc. has a market cap of $6.95 billion; its shares were traded at around $17.97 with a P/E ratio of 14.4 and P/S ratio of 0.6.


On March 30, SAIC Inc. reported results for the fourth quarter of 2009. Revenues for the quarter were $2.68 billion, up 7 percent from $2.52 billion in the fourth quarter of fiscal year 2009. Full-year revenues were $10.85 billion, up 8 percent from fiscal year 2009. Internal revenue growth, which includes year-over-year performance of acquisitions, represented 4 percentage points of the consolidated revenue growth for the quarter and 6 percentage points of the consolidated revenue growth for the fiscal year.


SAIC Inc. is in the portfolios of George Soros and Ron Baron.


This month, Buy:: Director Thomas F Frist III and Buy:: Chairman of the Board Kenneth C Dahlberg both bought shares of SAI. Sell:: Executive Vice President Arnold L Punaro, Sell:: Director Jere A Drummond and Sell:: Executive Vice President Joseph P Walkush sold shares in January.


Natural Resource Partners L.P. (NRP): Director W Jr Scott Bought 16,000 Shares


Director of Natural Resource Partners L.P. (NRP) W Jr Scott bought 16,000 shares on 04/13/2010 at an average price of $25.26.


Natural Resource LP is a master limited partnership that engages principally in the business of owning and managing coal royalty properties in the three major coal-producing regions of the United States. Natural Resource Partners L.P. has a market cap of $1.75 billion; its shares were traded at around $25.26 with a P/E ratio of 19.8 and P/S ratio of 6.9. The dividend yield of Natural Resource Partners L.P. stocks is 8.5%. Natural Resource Partners L.P. had an annual average earning growth of 20.5% over the past 10 years.


On February 11, National Resource LP announced distributable cash flow, a non-GAAP measure, of $178.4 million for the year ended December 31, 2009, down 16% from the prior year. Distributable cash flow is reconciled to net cash provided by operating activities, a GAAP measure, in a table attached. Net income attributable to the limited partners was $79.0 million, or $1.17 per unit, for the full year 2009 versus $127.5 million, or $1.95 per unit, for the full year 2008.


Last week, Buy:: Director W W Jr Scott bought 16,000 shares of NRP stock.


Sonic Corp. (SONC): Director Kathy L Taylor Bought 4,150 Shares


Director of Sonic Corp., Kathy L Taylor, bought 4,150 shares on 4/14/10 at an average price of $12.15.


Sonic Corp. operates and franchises one of the largest chain ofdrive-in restaurants in the United States. Sonic Corp. has a market cap of $742.3 million; its shares were traded at around $12.15 with a P/E ratio of 19.6 and P/S ratio of 1.1. Sonic Corp. had an annual average earning growth of 18.2% over the past 10 years. GuruFocus rated Sonic Corp. the business predictability rank of 4.5-star.


On March 23, Sonic Corp. announced results for the second fiscal quarter ended February 28, 2010. Net loss per diluted share totaled $0.01 versus net income per diluted share of $0.14 in the year-earlier quarter, with the latter including a $0.06 gain from the purchase of debt at a discount in the second quarter of fiscal 2009.


This month, Sell:: Exec. Vice Pres. & CFO Stephen C Vaughan sold shares of SONC and Buy:: Director Kathy L Taylor bought 4,150 shares.


Spectrum Pharmaceuticals Inc. (SPPI): Director Julius A Vida Bought 2,500 Shares


Director of Spectrum Pharmaceuticals Inc., Julius A Vida, bought 2,500 shares on 4/12/10 at an average price of $4.8.


Spectrum Pharmaceuticals, Inc. is opportunistically acquiring and advancing a diversified portfolio of oncology drug candidates that meet critical health challenges for which there are few other treatment options. Spectrum Pharmaceuticals Inc. has a market cap of $234.2 million; its shares were traded at around $4.8 with and P/S ratio of 6.1.


On April 5, Spectrum Pharmaceuticals, Inc. announced results for the fourth quarter of 2009. Consolidated revenue of $8.6 million was comprised of product sales of $5.2 million.. This compares to $8.0 million in revenue in the same period in 2008. The Company recorded a net profit of $10.2 million, or $0.21 (basic earnings) and $0.20 (diluted earnings) per share, compared to a net loss of $8.9 million, or ($0.28) basic and diluted loss per share, in the fourth quarter of 2008, after reporting $19.8 million of income resulting from the reclassification of common stock warrants from equity to liability.


This month, Buy:: Chairman, CEO & President Rajesh C Md Shrotriya and Buy:: Director Julius A Vida bought shares of SPPI stock.Buy:: Director Mitchell P. Cybulski bought 20,000 shares in February.


For the complete list of stocks that bought by their company executives, go to: Insider Buys.